WAT : Analysis & Opinions

  1. Agilent Isn't Making It Easy On Investors

    May 15, 2013
    Core operating performance at Agilent needs to improve
  2. FEI Still A Big Play On The Very Small

    February 11, 2013
    FEI has excellent growth potential, but valuation is a bit steep.
  3. Forget Nano, FEI Is Real

    April 10, 2012
    Forget the nano hype, FEI is a real company in the analytical technology space.
  4. Neogen Is Almost Cheap

    December 30, 2011
    Neogen has to do more to validate this price.
  5. R&D The Future For Life Sciences Equipment Firms

    September 20, 2011
    Finding new healthcare solutions will be a paramount concern going forward. For investors, the best way to profit from this ...
  6. Illumina Lights Up Again

    April 29, 2011
    Illumina is a torrid grower, and growth investors seem to be willing to pay any price.
  7. Thermo Fisher Pays A High Price For Quality

    December 15, 2010
    Thermo Fisher makes a very reasonable purchase but pays a price to do so.
  8. A Fistfull Of Life Sciences

    October 29, 2010
    The life sciences field is showing encouraging growth and mostly reasonable valuations.
  9. Agile Agilent

    August 18, 2010
    Agilent may defy easy categorization, but its quality does not depend on labels.
  10. Bidding Frenzy Hits Genetic Testing Stocks

    June 13, 2008
    Genetic testing to assess future disease risk is about to go mainstream. This promted a take-over free-for-all in the sector.
Trading Center